scispace - formally typeset
Open AccessJournal ArticleDOI

Diabetes and Ramadan: Practical guidelines.

Reads0
Chats0
TLDR
The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan.
About
This article is published in Diabetes Research and Clinical Practice.The article was published on 2017-04-01 and is currently open access. It has received 247 citations till now.

read more

Citations
More filters
Journal ArticleDOI

The Effects of Daily Fasting Hours on Shaping Gut Microbiota in Mice

TL;DR: It is indicated that intermittent fasting shapes gut microbiota in healthy mice, and the length of daily fasting interval may influence the outcome of intermittent fasting.
Journal ArticleDOI

Diabetes and Ramadan: Practical guidelines 2021

TL;DR: The International Diabetes Federation (IDF) and Diabetes and Ramadan (DaR) International Alliance have come together to provide a substantial update to the previous guidelines as mentioned in this paper , which includes key information on fasting during Ramadan with type 1 diabetes, the management of diabetes in people of elderly ages and pregnant women, the effects of Ramadan on one's mental wellbeing, changes to the risk of macrovascular and microvascular complications, and areas of future research.
Journal ArticleDOI

Type 2 diabetes patient’s perspective on Ramadan fasting: a qualitative study

TL;DR: Evaluating the beliefs, experience and diabetes management strategies of type 2 diabetes mellitus (T2DM) Muslim patients that chose to fast during Ramadan found Muslims are optimistic about their well-being when fasting during Ramadan.
Journal ArticleDOI

Bibliometric analysis of the literature on Ramadan fasting and diabetes in the past three decades (1989-2018).

TL;DR: This is the first bibliometric study on diabetes in Ramadan, a good starting point to evaluate gaps in research activity in the field and should help identify future research directions and foster more collaboration.
Journal ArticleDOI

Ramadan and Diabetes: A Narrative Review and Practice Update

TL;DR: There is sufficient evidence across the different classes of therapeutic hypoglycaemic agents in terms of safety and efficacy to enable informed decision-making and provide a breadth of therapeutic options for the patient and the healthcare professional, even if the professional advice is to abstain.
References
More filters
Journal ArticleDOI

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

TL;DR: Clinical trials with the incretin mimetic exenatide and liraglutide show reductions in fasting and postprandial glucose concentrations, and haemoglobin A1c (HbA1c) associated with weight loss, but long-term clinical studies are needed to determine the benefits of targeting the inc retin axis for the treatment of type 2 diabetes.
Journal ArticleDOI

Impact of sleep debt on metabolic and endocrine function

TL;DR: Sleep debt has a harmful impact on carbohydrate metabolism and endocrine function similar to those seen in normal ageing and, therefore, sleep debt may increase the severity of age-related chronic disorders.
Journal ArticleDOI

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

TL;DR: Careful postmarketing surveillance for adverse effects, especially among the DPP4 inhibitors, and continued evaluation in longer-term studies and in clinical practice are required to determine the role of this new class of pharmacotherapies for type 2 diabetes.
Journal ArticleDOI

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study

TL;DR: There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.
Journal ArticleDOI

Adiponectin: action, regulation and association to insulin sensitivity

TL;DR: Adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.
Related Papers (5)